![[Translate to English:]](/fileadmin/_processed_/5/6/csm_willkommen_d34eda0786.png "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/e/1/csm_ueberuns_c1c8cb27e1.png "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/8/5/csm_ACL_11_GrafikFingerTablet_LB8_c4ce258375.jpg "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/b/8/csm_studien_6aaab3c7bf.jpg "[Translate to English:]")
![[Translate to English:]](/fileadmin/_processed_/6/4/csm_publikaitonen_4abdce50fc.png "[Translate to English:]")
Scope
After sending in a plasma sample according to the request form (see link), the concentration of voriconazole in the plasma is determined in µg/mL. The value will be reported to the sender within 72 hours. If an appraisal of the value is desired, the dosage regimen of the respective patient must be indicated on the request form. This makes an individual and specific evaluation of findings possible. The report of the findings and the values takes place separately.
Please contact us if you have any questions regarding therapeutic drug monitoring of voriconazole: Dr. rer. nat. Jürgen Burhenne:06221 56-36395 oder juergen.burhenne(at)med.uni-heidelberg.de.
